Mezigdomide and Multiple Myeloma

Jake Shortt

doi:10.1056/NEJMe2307370

Mezigdomide and Multiple Myeloma

Jake Shortt

Medicine Monash Health

Research output: Contribution to journal › Editorial › Other

8 Citations (Scopus)

Original language	English
Pages (from-to)	1046-1050
Number of pages	4
Journal	The New England Journal of Medicine
Volume	389
Issue number	11
DOIs	https://doi.org/10.1056/NEJMe2307370 https://doi.org/10.1056/NEJMe2307370
Publication status	Published - Sept 2023

Keywords

Cancer
Genetics
Genetics General
Hematology/Oncology
Hematology/Oncology General
Leukemia/Lymphoma
Treatments in Oncology

Access to Document

Cite this

@article{a9a0d0e356784effaa6b4bba361af132,

title = "Mezigdomide and Multiple Myeloma",

keywords = "Cancer, Genetics, Genetics General, Hematology/Oncology, Hematology/Oncology General, Leukemia/Lymphoma, Treatments in Oncology",

author = "Jake Shortt",

year = "2023",

month = sep,

doi = "10.1056/NEJMe2307370",

language = "English",

volume = "389",

pages = "1046--1050",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "11",

}

TY - JOUR

T1 - Mezigdomide and Multiple Myeloma

AU - Shortt, Jake

PY - 2023/9

Y1 - 2023/9

KW - Cancer

KW - Genetics

KW - Genetics General

KW - Hematology/Oncology

KW - Hematology/Oncology General

KW - Leukemia/Lymphoma

KW - Treatments in Oncology

UR - https://www.scopus.com/pages/publications/85171309997

U2 - 10.1056/NEJMe2307370

DO - 10.1056/NEJMe2307370

M3 - Editorial

C2 - 37646699

AN - SCOPUS:85171309997

SN - 0028-4793

VL - 389

SP - 1046

EP - 1050

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 11

ER -

Mezigdomide and Multiple Myeloma

Keywords

Access to Document

Other files and links

Cite this